This post was originally published on this site
Viatris announced earnings per share of $-0.22 on revenue of $4.33B. Analysts polled by Investing.com anticipated EPS of $0.8285 on revenue of $4.35B.
Viatris shares are up 5% from the beginning of the year, still down 10.74% from its 52 week high of $16.29 set on May 17, 2021. They are outperforming the S&P 500 which is down 8.01% from the start of the year.
Viatris’s report follows an earnings matched by Roche Holding ADR on February 3, who reported EPS of $1.29 on revenue of $17.54B, compared to forecasts EPS of $1.29 on revenue of $17.1B.
Pfizer had beat expectations on February 8 with fourth quarter EPS of $1.08 on revenue of $23.84B, compared to forecast for EPS of $0.8742 on revenue of $24.16B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
